The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
April 24, 2012 (Prague, Czech Republic) — A gene-expression test for impending cardiac transplant rejection, shown in several US-based trials to have a high negative predictive value that could help ...
Paris & Strasbourg, France - May 25, 2016 - DIAXONHIT (Alternext: ALEHT, FR0004054427), the leading French provider of specialty in-vitro diagnostic solutions for transplantation, infectious diseases ...
This transplant test is facing a death sentence unless a rejection is on the horizon. Its manufacturer warns that it will have to stop selling its commonly used blood test for detecting imminent organ ...
BRISBANE, Calif.--(BUSINESS WIRE)--XDx, Inc., a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high value non-invasive gene expression ...
BRISBANE, Calif.--(BUSINESS WIRE)-- XDx, Inc., a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high value non-invasive gene expression ...
A heart transplant is the removal of a diseased heart and replacement with a donor heart from someone who has just died (the donor). According to the Organ Procurement and Transplantation Network ...
For most of us, giving blood is nothing to get excited about. For Richard Locke, it's a joy. And if he seems almost giddy, it helps to understand what a six month check up used to be like, after ...
BRISBANE, Calif.--(BUSINESS WIRE)--XDx, Inc., a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high value non-invasive tests to monitor ...
This Peninsula company would be paid less by Medicare than it costs to perform its test and related services for heart transplant rejection. But it has 30 days to make its case to the federal agency ...
The AlloMap Test is a noninvasive, multi-gene molecular diagnostics blood test used to aid in the identification of heart transplant recipients with stable allograft function who have a low ...
SOUTH SAN FRANCISCO, Calif., Oct. 19, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results